News

Video

Optimal Patient Management in Hepatitis C Treatment

Author(s):

Lauren Santye, Assistant Editor

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses the components of an effective patient management program to optimize adherence.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses the components of an effective patient management program to optimize adherence.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
American Captial Building.
Related Content
API-CAT Findings Support Existing NCCN Cancer-Associated VTE Guidance
September 4th 2025

API-CAT Findings Support Existing NCCN Cancer-Associated VTE Guidance

Belkis Kaplan, PharmD Resident
Pharmacy Focus Oncology Edition Podcast
September 4th 2025

Protecting Community Oncology Practices in the Wake of the IRA

Alexandra Gerlach, Associate Editor
A middle-aged breast cancer woman with clothing around her head effected from chemo therapy sitting on wheel chair and hold hand of her daughter with hope and trust in love. | Image Credit: Bangkok Click Studio | stock.adobe.com
September 4th 2025

Dual Inhibition of KAT6A/B and Menin: A Promising Strategy for ER+ Breast Cancer

Danielle Valletti, Assistant Editor
Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage
September 4th 2025

Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage

Jennifer Griffin, PharmD, MS Luke Halpern, Assistant Editor
Patient self-administering subcutaneous injection | Image Credit: © - stock.adobe.commanusapon
September 4th 2025

Subcutaneous Bortezomib Associated With Reduced Incidence of Peripheral Neuropathy in Multiple Myeloma

Alexandra Gerlach, Associate Editor
Close up of prostate cancer cells - Image credit: Science RF | stock.adobe.com
September 4th 2025

FDA Approves 3-Month Leuprolide Mesylate 21-mg Formulation for Advanced Prostate Cancer

Kennedy Ferruggia, Assistant Editor
© 2025 MJH Life Sciences

All rights reserved.